InChI=1S/C31H52N2O26S/c1- 8- 17(40) 20(43) 21(44) 28(53- 8) 57- 25- 16(33- 10(3) 37) 27(46) 54- 13(6- 35) 23(25) 56- 29- 22(45) 26(19(42) 14(55- 29) 7- 52- 60(49,50) 51) 59- 31(30(47) 48) 4- 11(38) 15(32- 9(2) 36) 24(58- 31) 18(41) 12(39) 5- 34/h8,11- 29,34- 35,38- 46H,4- 7H2,1- 3H3,(H,32,36) (H,33,37) (H,47,48) (H,49,50,51) /t8- ,11- ,12+,13+,14+,15+,16+,17+,18+,19- ,20+,21- ,22+,23+,24+,25+,26- ,27+,28- ,29- ,31- /m0/s1 |
NWWSDBBCJHHGNB-UQTBNESHSA-N |
[H] [C@] 1(O[C@@] (C[C@H] (O) [C@H] 1NC(C) =O) (O[C@H] 1[C@@H] (O) [C@@H] (COS(O) (=O) =O) O[C@@H] (O[C@@H] 2[C@@H] (CO) O[C@@H] (O) [C@H] (NC(C) =O) [C@H] 2O[C@@H] 2O[C@@H] (C) [C@@H] (O) [C@@H] (O) [C@@H] 2O) [C@@H] 1O) C(O) =O) [C@H] (O) [C@H] (O) CO |
|
epitope
The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
|
|
View more via ChEBI Ontology
Outgoing
|
α- L- Fucp- (1→3)- [α- Neup5Ac- (2→3)- β- D- Galp6S- (1→4)]- β- D- GlcpNAc
(CHEBI:71558)
has role
epitope
(CHEBI:53000)
α- L- Fucp- (1→3)- [α- Neup5Ac- (2→3)- β- D- Galp6S- (1→4)]- β- D- GlcpNAc
(CHEBI:71558)
is a
amino tetrasaccharide
(CHEBI:59412)
α- L- Fucp- (1→3)- [α- Neup5Ac- (2→3)- β- D- Galp6S- (1→4)]- β- D- GlcpNAc
(CHEBI:71558)
is a
glucosamine oligosaccharide
(CHEBI:22485)
|
|
5- acetamido- 3,5- dideoxy- D- glycero- α- D- galacto- non- 2- ulopyranonosyl- (2→3)- 6- O- sulfo- β- D- galactopyranosyl- (1→4)- [α- L- fucopyranosyl- (1→3)]- 2- acetamido- 2- deoxy- D- glucopyranose
|
5- acetamido- 3,5- dideoxy- D- glycero- α- D- galacto- non- 2- ulopyranonosyl- (2→3)- 6- O- sulfo- β- D- galactopyranosyl- (1→4)- [6- deoxy- α- L- galactopyranosyl- (1→3)]- 2- acetamido- 2- deoxy- D- glucopyranose
|
IUPAC
|
α- L- Fuc- (1→3)- [α- Neu5Ac- (2→3)- β- D- Gal6S- (1→4)]- β- D- GlcNAc
|
ChEBI
|
α- L- fucosyl- (1→3)- [N- acetyl- α- neuraminyl- (2→3)- 6- O- sulfo- β- D- galactosyl- (1→4)]- N- acetyl- β- D- glucosamine
|
ChEBI
|
β- D- glucopyranose, O- 5- (acetylamino)- 3,5- dideoxy- D- glycero- α- D- galacto- 2- nonulopyranonosyl- (2→3)- O- 6- O- sulfo- β- D- galactopyranosyl- (1→4)- O- [6- deoxy- α- L- galactopyranosyl- (1→3)]- 2- (acetylamino)- 2- deoxy-
|
ChEBI
|
N- acetyl- α- D- neuraminyl- (2→3)- 6- O- sulfo- β- D- galactosyl- (1→4)- [α- L- fucosyl- (1→3)]- N- acetyl- β- D- glucosamine
|
ChEBI
|
Neu5Aca2-3(6S)Galb1-4(Fuca1-3)GlcNAcb
|
ChEBI
|
Neu5Acα2-3(6-O-Su)Galβ1-4(Fucα1-3)GlcNAcβ
|
ChEBI
|
O- 5- (acetylamino)- 3,5- dideoxy- D- glycero- α- D- galacto- 2- nonulopyranonosyl- (2→3)- O- 6- O- sulfo- β- D- galactopyranosyl- (1→4)- O- [6- deoxy- α- L- galactopyranosyl- (1→3)]- 2- (acetylamino)- 2- deoxy- β- D- glucopyranose
|
ChEBI
|
WURCS=2.0/4,4,3/[a2122h- 1b_1- 5_2*NCC/3=O][a1221m- 1a_1- 5][a2112h- 1b_1- 5_6*OSO/3=O/3=O][Aad21122h- 2a_2- 6_5*NCC/3=O]/1- 2- 3- 4/a3- b1_a4- c1_c3- d2
|
GlyTouCan
|
19443021
|
PubMed citation
|
Europe PMC
|
25568069
|
PubMed citation
|
Europe PMC
|
31537530
|
PubMed citation
|
Europe PMC
|
|